Legal Opinion

Health Care Service Corp. v. Mylan Laboratories, Inc.

District Court, District of Columbia

Decided December 23, 2003No. MDL No. 1290; Misc. No. 99-276 TFH/JMF; Nos. 01-2646, 02-1299 TFH/JMFPublishedCited by 12 opinions

1Opinion of the Court

MEMORANDUM OPINION

FACCIOLA, United States Magistrate Judge.

Plaintiffs in this antitrust case are Blue Cross Blue Shield of Minnesota and of Massachusetts, the Federated Mutual Insurance Company, and the Health Care Service Corporation (hereafter collectively called “the Blues”). They opted out of a settlement premised on antitrust violations by the defendant, Mylan Laboratories (hereafter “My-lan”) and their complaint has now survived Mylan’s motion to dismiss. According to the Chief Judge, plaintiffs’ allegations of injury based on Mylan’s increased prices for lora-*14zepam and clorazepate were…

2Cases cited2 opinions

  1. Alexander v. Federal Bureau of InvestigationDistrict Court, District of Columbia · 2000
  2. Bethea v. ComcastDistrict Court, District of Columbia · 2003

3Cited by12 opinions

  1. Averill v. Gleaner Life Insurance SocietyDistrict Court, N.D. Ohio · 2009
  2. Anthony C. Lustig v. AzGen Scientific Holdings PLCDistrict Court, N.D. California · 2020
  3. BMO Bank N.A. v. CheemaDistrict Court, E.D. California · 2024
  4. Board of Trustees of the Laborers Health and Welfare Plan for Northern California v. GalvezDistrict Court, N.D. California · 2020
  5. Carmen John Perri v. CA 199 Arcadia Owner LLCDistrict Court, C.D. California · 2020

7 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API